Changes in Muscle Strength, Inflammatory Markers, and Body Composition in Response to Alternate Day Fasting Combined With Krill Oil Supplementation in Adults With Overweight and Obesity
Obesity Associated Disorder
About this trial
This is an interventional prevention trial for Obesity Associated Disorder focused on measuring Obesity, Cardiometabolic risk factors, Fat mass, Fat free mass, Body composition, Muscle strength, LCn-3PUFA
Eligibility Criteria
Inclusion Criteria: Healthy (male/female) body mass index (BMI) of 25 - 39.9 kg/m2 Aged between 25 and 65 years stable body weight for at least three months Exclusion Criteria: Smokers Food allergy On any dietary supplements or dietary regimes at the time of the study Participants with systolic/diastolic <90/60 mmHg and >140/90 mmHg
Sites / Locations
- University of Glasgow, New Lister BuildingRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Krill oil capsules (LC n-3 PUFAs)
Vegetable oil capsules
4 g/day krill oil (SuperbaBoostTM), with each 1g capsule containing 191mg EPA, 94mg DHA and 78mg choline.
4g/day of mixed vegetable oil (a mixture of olive oil (extra virgin, cold-pressed), maize oil (refined), palm kernel oil (refined) and medium-chain triglycerides, in the ratio 4:4:3:2).